Align 4-(gamma-glutamylamino)butanal dehydrogenase (EC 1.2.1.99) (characterized)
to candidate WP_040639379.1 MICLODRAFT_RS25285 aldehyde dehydrogenase family protein
Query= BRENDA::P23883 (495 letters) >NCBI__GCF_000262405.1:WP_040639379.1 Length = 478 Score = 332 bits (850), Expect = 2e-95 Identities = 193/475 (40%), Positives = 279/475 (58%), Gaps = 11/475 (2%) Query: 24 INGEYTAAAENETFETVDPVTQAPLAKIARGKSVDIDRAMSAARGVFERGDWSLSSPAKR 83 I G+ A++ T + + PV + LA+IA G + DID A+ AAR FE G W + +R Sbjct: 7 IGGQERPASDGMTLDVLSPVDGSLLARIAAGTTQDIDEAVKAARAAFE-GAWGELTATER 65 Query: 84 KAVLNKLADLMEAHAEELALLETLDTGKPIRHSLRDDIPGAARAIRWYAEAIDKVYGEVA 143 +L KLA +EA A+ELA+LE+ D GKP+R S D I AR +Y A DK++G+V Sbjct: 66 GRLLMKLATAVEARADELAILESRDNGKPLRQSRADAI-ALARYFEFYGSAADKLHGDVI 124 Query: 144 TTSSHELAMIVREPVGVIAAIVPWNFPLLLTCWKLGPALAAGNSVILKPSEKSPLSAIRL 203 + + R P GV IVPWN+P+ + +G ALAAGN+ ++KP+E + L+ +R+ Sbjct: 125 PYLNTHFIGVERVPHGVTGHIVPWNYPMQIFGRSVGAALAAGNATVVKPAEDASLTILRV 184 Query: 204 AGLAKEAGLPDGVLNVVTGFGHEAGQALSRHNDIDAIAFTGSTRTGKQLLKDAGDSNMKR 263 + LA+E G PDG LNVVTG G AG AL+ H+ ID ++FTGS TG ++ A N Sbjct: 185 SALAREVGFPDGALNVVTGLGRTAGAALAAHSGIDFLSFTGSPETG-TAVQTAAARNHVG 243 Query: 264 VWLEAGGKSANIVFADCPDLQQAASATAAGIFYNQGQVCIAGTRLLLEESIADEFLALLK 323 V LE GGKSA +VF D DL++A I N GQ C AG+RLL++ I + + + Sbjct: 244 VTLELGGKSAQVVFDDA-DLERALPTLVNAIIQNGGQTCSAGSRLLIQRGIFQDVVDAVA 302 Query: 324 QQAQNWQPGHPLDPATTMGTLIDCAHADSVHSFIREGESKGQLLLDGRNAGLAAAIG--- 380 ++ + + GHP + +G +I+ A V ++ G ++G ++ L A G Sbjct: 303 ERFRTLRAGHP-EHEPDLGPMINQAQQRRVLGYLERGRNEGLNVVGEGVVALDAPAGGYY 361 Query: 381 --PTIFVDVDPNASLSREEIFGPVLVVTRFTSEEQALQLANDSQYGLGAAVWTRDLSRAH 438 P V + LS+EE+FGPVLV T F E +A +LAN + YGL A VWTRD R+ Sbjct: 362 VAPAFLAPVPHESILSQEEVFGPVLVATPFDDEAEATRLANGTPYGLAAGVWTRDAMRST 421 Query: 439 RMSRRLKAGSVFVNNYN-DGDMTVPFGGYKQSGNGRDKSLHALEKFTELKTIWIS 492 R++R ++AG VFVN Y G + +PFGG+ +SG+GR+K L +FT KT+ I+ Sbjct: 422 RVARSIRAGQVFVNCYGAGGGIELPFGGFGRSGHGREKGFEGLVEFTTTKTLVIA 476 Lambda K H 0.317 0.133 0.389 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 536 Number of extensions: 28 Number of successful extensions: 7 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 495 Length of database: 478 Length adjustment: 34 Effective length of query: 461 Effective length of database: 444 Effective search space: 204684 Effective search space used: 204684 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 52 (24.6 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory